| mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.8 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.9 |
| mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.9 |
| mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.9 |
| mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
| mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.0071 |
0.9 |
| mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
| mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
| mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
-0.0073 |
0.9 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |